ArticleTherapeutic advances in medical oncology2020

EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer.

Zachary D Crees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.